Project Number 5U01AG066757-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator TSAI, LI-HUEI Principal Investigator First Name JOEL Principal Investigator Last Name BLANCHARD Awardee Organization MASSACHUSETTS INSTITUTE OF TECHNOLOGY Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-820: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $1,595,511 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YUAN, JEAN
